Risk-benefit ratio assessment for stroke prevention in intermediate risk atrial fibrillation patients: will TEE-based aspirin treatment fill the gap?

M. D. Smit, I. C. Van Gelder*

*Corresponding author for this work

Research output: Contribution to journalEditorialAcademicpeer-review

1 Citation (Scopus)
Original languageEnglish
Pages (from-to)212-213
Number of pages2
JournalNetherlands Heart Journal
Volume19
Issue number5
DOIs
Publication statusPublished - May-2011

Keywords

  • THROMBOEMBOLISM

Cite this